Denver, Colorado – Markets are digesting a mix of breakthrough biotech ambitions, AI-driven profitability, semiconductor positioning for infrastructure build-outs, and fresh 52-week highs in apparel and communications.
Kraig Biocraft Laboratories (OTCQB:KBLB): From Lab Bench to Loom
Kraig Biocraft Laboratories is approaching what could be a historic inflection point in transgenic biotechnology. The company is preparing to deploy approximately one million proprietary spider silk silkworm eggs across three production facilities in Vietnam, targeting output of up to 10 metric tons per month of recombinant spider silk cocoons beginning in March.
The scientific groundwork dates back years, including validation published in the Proceedings of the National Academy of Sciences confirming that transgenic silkworms produced fibers tougher than conventional silk and comparable to native spider dragline silk. The key distinction: Kraig’s engineered silkworms spin recombinant spider silk as part of their natural physiology, rather than requiring complex downstream purification typical in pharmaceutical-focused transgenic systems.
If commercial production proceeds as outlined, KBLB could become only the second company in history to achieve sustained commercial-scale output from a transgenic animal platform—and the first to do so with a biodegradable structural fiber.
The lone historical precedent remains ATryn, later incorporated into Sanofi (NASDAQ:SNY) following its acquisition of Genzyme. That milestone underscores how rare durable commercial success has been in this corner of biotechnology.
Investor attention is now fixed on brand disclosures. Kraig has indicated collaborations with three nationally recognized global brands spanning luxury fashion, performance sportswear, and athletic equipment. Initial deliveries are expected once material preparation is complete, setting up a potentially defining spring for the company.
Athleticwear may be the “low-hanging fruit,” but the longer-term vision includes medical materials, wearable tech, and anti-ballistic applications, markets that historically reward high-performance fibers after extended qualification cycles.
Apparel Names Ride Strength: New Highs in Focus
The broader performance apparel complex is also drawing attention.
-
Under Armour (NYSE:UAA) hit a new 52-week high of $8.09 after releasing unaudited fiscal Q3 2026 results earlier this month.
-
Gap Inc. (NYSE:GAP) reached a new 52-week high of $29.36 ahead of its March 5, 2026 fourth quarter and fiscal 2025 earnings report.
For companies like Kraig Biocraft targeting textile integration, strength in athletic and lifestyle brands underscores ongoing demand in performance-driven apparel categories.
AXT (NASDAQ:AXTI): AI Infrastructure Tailwinds
AXT shares touched a new 52-week high of $30.80 following fourth quarter and full-year 2025 results.
Q4 revenue came in at $23.0 million, down sequentially from $28.0 million, while GAAP gross margin improved year-over-year to 20.9%. The company posted a GAAP net loss of $3.5 million for the quarter.
CEO Morris Young acknowledged export permit constraints in Q4 but noted the company has received permits in early 2026 and expects sequential revenue growth in Q1, “driven primarily by growth in indium phosphide for the AI infrastructure build-out.” He added that AXT is broadening its customer base to include Tier-1 companies and is on track to double indium phosphide manufacturing capacity this year.
As AI data center expansion accelerates globally, compound semiconductor substrates remain a foundational piece of the hardware stack.
RingCentral (NYSE:RNG): AI + Cash Flow + Capital Returns
RingCentral also hit a new 52-week high of $40.64 after reporting strong fourth quarter and fiscal 2025 results.
Full-year 2025 highlights:
-
Total revenue: $2.515 billion, up 5%
-
Operating cash flow: $617 million, up 28% YoY
-
Free cash flow: $530 million, up 32% YoY
-
GAAP operating income: $121 million vs. $3 million in 2024
In Q4 alone, GAAP operating margin expanded to 6.6%, and GAAP EPS improved to $0.26 from a loss last year.
Founder and CEO Vlad Shmunis said the company delivered “record free cash flow,” adding that AI is proving to be a strong tailwind, with ARR from customers using at least one monetized AI product more than doubling year-over-year and approaching 10% of total ARR.
The company initiated its first quarterly dividend of $0.075 per share and increased its share repurchase authorization to $500 million, pairing AI growth with tangible shareholder returns.
RingCentral also announced integration efforts with OpenAI to advance enterprise-grade voice AI, alongside recognition from IDC MarketScape and Metrigy in UCaaS and AI-enabled contact center categories.
Guidance for 2026 calls for continued revenue growth, expanding margins, free cash flow of $580–$600 million, and further deleveraging.
Rackspace (NASDAQ:RXT) & Palantir (NASDAQ:PLTR): AI in Production
Rackspace continues to run, since this week’s announcement of a strategic partnership with Palantir to help enterprises deploy Palantir’s Foundry and Artificial Intelligence Platform (AIP) in production under a governed managed operations model.
Rackspace will provide cloud hosting, data migration, and operational management, with plans to scale its Palantir-trained engineering team from 30 to over 250 within 12 months.
Rackspace CEO Gajen Kandiah said organizations need AI that works “in production, not just in demos,” while Palantir’s Sameer Kirtane noted that Palantir AIP is reducing migration timelines from years to days in complex data environments.
For regulated industries, the partnership emphasizes sovereignty-compliant deployments in private cloud and UK sovereign data centers, highlighting the increasing importance of governance alongside AI capability.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
About 24/7 Market News
In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.